Lifeline Scientific, Inc Additional Listing (1257B)
October 02 2015 - 10:27AM
UK Regulatory
TIDMLSIC
RNS Number : 1257B
Lifeline Scientific, Inc
02 October 2015
Lifeline Scientific, Inc.
("Lifeline" or the "Company")
Additional Listing
Lifeline Scientific (AIM: LSIC), the transplantation technology
company, announces the issue of 1,668 unrestricted shares under
ISIN number US53223V1017 following the cashless exercise of 15,750
share options.
Application has been made to the London Stock Exchange for
admission to AIM of 1,668 common shares of USD0.01 each. It is
expected that admission will become effective in the Shares on or
around the 8 October 2015.
Subsequent to the admission above there will be 19,530,031
common shares in issue. Each share has the right to one vote. The
Company holds no shares in Treasury. Therefore for the purposes of
the FCA Disclosure and Transparency Rules the total number of
voting rights in the Company is 19,530,031.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine whether they are
required to notify the Company of their interests in, or change to
their interests in, Lifeline Scientific, Inc. under the AIM Rules
of the London Stock Exchange and the FCA's Disclosure and
Transparency Rules.
2 October 2015
For further information:
Lifeline Scientific, www.lifeline-scientific.com
Inc.
David Kravitz, CEO Tel: +1 847 294 0300
Lisa Kieres, CFO Tel: +1 847 294 0300
Panmure Gordon (UK) Tel: +44 (0)20 7886 2500
Limited
Freddy Crossley (Corporate
Finance)
Maisie Atkinson (Corporate
Broking)
Walbrook PR Limited Tel: +44 (0) 20 7933 8780 or
lifeline@walbrookpr.com
Paul McManus Mob: +44 (0)7980 541 893
Mike Wort Mob: +44 (0)7900 608 002
About Lifeline Scientific Inc.
Lifeline Scientific, Inc. is a Chicago-based global medical
technology company with regional offices in Brussels and Sao Paulo.
The Company's focus is the development of innovative products that
improve transplant outcomes and lower the overall costs of
transplantation. Its lead product, LifePort Kidney Transporter, is
the global market-leading medical device for hypothermic machine
preservation of donor kidneys. LifePorts and novel solutions
designed for preservation of other organs are in development, with
LifePort Liver Transporter next in line for commercial launch. For
more information please visit www.lifeline-scientific.com
About LifePort Kidney Transporter
Created with the challenges of organ recovery and transport in
mind, LifePort Kidney Transporter is a proprietary medical device
designed to help improve kidney preservation, evaluation and
transport prior to transplantation. It has been widely studied in
clinical trials throughout the world and is the standard of care
for machine preservation of kidneys. Employed by surgeons in over
200 leading transplant programmes in 29 countries, LifePorts have
successfully preserved more than 70,000 kidneys indicated for
clinical transplant. For more information please visit
www.organ-recovery.com
About LifePort Liver Transporter
LifePort Liver Transporter is modelled upon the clinically
proven technology platform of LifePort Kidney Transporter and the
Company's early HMP prototype successfully used in clinical
transplant studies by surgeons at New York-Presbyterian
Hospital/Columbia University Medical Center. LifePort Liver
Transporter and the Company's proprietary machine preservation
solution, Vasosol(R), are in the process of US and international
regulatory registrations. The system is designed to help improve
outcomes in liver transplantation by enabling the clinical use of
hypothermic machine perfusion, and has been developed in
consultation with clinical and research teams specialising in liver
transplantation at Columbia University Medical Center and the
University of Chicago. The system employs a rugged, streamlined
ergonomic design for ease of use and transportability from donor
bedside to recipient operating room. For more information please
visit: http://www.organ-recovery.com/pipeline.php
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISZMMGGDZDGKZM
(END) Dow Jones Newswires
October 02, 2015 10:27 ET (14:27 GMT)
Lifeline Sci (LSE:LSIC)
Historical Stock Chart
From Apr 2024 to May 2024
Lifeline Sci (LSE:LSIC)
Historical Stock Chart
From May 2023 to May 2024